New Ray Medicine International Holding Limited (HKG:6108)
Hong Kong · Delayed Price · Currency is HKD 0.2070
+0.0010 (0.49%)
At close: Jun 1, 2026
HKG:6108 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -20.07 | -31.01 | -22.17 | -77.95 | -2.82 |
Depreciation & Amortization | 3.53 | 3.31 | 6.21 | 6.43 | 5.75 |
Other Amortization | 2.11 | 3.49 | 3.56 | 3.74 | 3.86 |
Loss (Gain) From Sale of Assets | -0.12 | -0.14 | -0.48 | -0.38 | 0.01 |
Asset Writedown & Restructuring Costs | - | - | 3.83 | - | - |
Loss (Gain) From Sale of Investments | 4.18 | -3.93 | -0.42 | - | 2.99 |
Loss (Gain) on Equity Investments | - | - | - | - | -1.11 |
Stock-Based Compensation | - | - | - | 10.39 | - |
Provision & Write-off of Bad Debts | 7.89 | 5.71 | 4.07 | 4.62 | 4.65 |
Other Operating Activities | -0.42 | 9.64 | -2.22 | 36.99 | -1.8 |
Change in Accounts Receivable | -22.33 | -10.4 | -38.8 | -24.83 | 11.06 |
Change in Inventory | -2.66 | -2.61 | 1.98 | 40.59 | -61.82 |
Change in Accounts Payable | -21.54 | 21.17 | -0.96 | 0.07 | -19.14 |
Change in Other Net Operating Assets | -4.72 | - | - | - | - |
Operating Cash Flow | -54.14 | -4.77 | -45.41 | -0.32 | -58.39 |
Capital Expenditures | -0.31 | -0.62 | -0.04 | -8.7 | -0.06 |
Sale of Property, Plant & Equipment | 0.22 | 0.19 | 0.59 | 0.47 | - |
Investment in Securities | 7.41 | -33.01 | -10.2 | 6.71 | 129.87 |
Other Investing Activities | 0.69 | 2.53 | 3.64 | 3.13 | 1.3 |
Investing Cash Flow | 8.01 | -30.9 | -6.01 | 1.62 | 131.1 |
Short-Term Debt Issued | - | - | - | - | 11.38 |
Total Debt Issued | - | - | - | - | 11.38 |
Short-Term Debt Repaid | - | - | - | -10.41 | - |
Long-Term Debt Repaid | -1.15 | -1.48 | -0.98 | -1.94 | -0.98 |
Total Debt Repaid | -1.15 | -1.48 | -0.98 | -12.35 | -0.98 |
Net Debt Issued (Repaid) | -1.15 | -1.48 | -0.98 | -12.35 | 10.39 |
Issuance of Common Stock | 7.52 | - | - | - | - |
Other Financing Activities | -0.26 | -0.1 | -0.03 | -0.18 | -0.28 |
Financing Cash Flow | 6.11 | -1.58 | -1.01 | -12.52 | 10.11 |
Foreign Exchange Rate Adjustments | 5.19 | -2.45 | 1.97 | 15.48 | 1.57 |
Net Cash Flow | -34.84 | -39.7 | -50.46 | 4.26 | 84.4 |
Free Cash Flow | -54.45 | -5.39 | -45.45 | -9.02 | -58.45 |
Free Cash Flow Margin | -41.77% | -5.73% | -90.62% | -10.04% | -17.43% |
Free Cash Flow Per Share | -0.32 | -0.03 | -0.27 | -0.05 | -0.35 |
Cash Interest Paid | 0.14 | 0.1 | 0.03 | 0.18 | 0.28 |
Cash Income Tax Paid | - | - | - | 0.15 | - |
Levered Free Cash Flow | -49.63 | 13.89 | -30.07 | 49.6 | -69.84 |
Unlevered Free Cash Flow | -49.54 | 13.95 | -30.05 | 49.71 | -69.67 |
Change in Working Capital | -51.25 | 8.16 | -37.77 | 15.83 | -69.9 |